{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,19]],"date-time":"2026-04-19T06:51:34Z","timestamp":1776581494998,"version":"3.51.2"},"reference-count":52,"publisher":"Elsevier BV","issue":"15","license":[{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Progr\u00e8s en Urologie"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1016\/j.purol.2022.08.010","type":"journal-article","created":{"date-parts":[[2022,11,15]],"date-time":"2022-11-15T21:55:47Z","timestamp":1668549347000},"page":"1040-1065","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["French AFU Cancer Committee Guidelines Update 2022\u20132024: Adrenal tumor\u00a0\u2013\u00a0 Assessment of an adrenal incidetaloma and oncological management"],"prefix":"10.1016","volume":"32","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2630-9124","authenticated-orcid":false,"given":"P.H.","family":"Savoie","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6435-1948","authenticated-orcid":false,"given":"T.","family":"Murez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0241-021X","authenticated-orcid":false,"given":"P.","family":"Neuville","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Van Hove","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3775-6886","authenticated-orcid":false,"given":"L.","family":"Rocher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Fl\u00e9chon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Camparo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4368-5890","authenticated-orcid":false,"given":"L.","family":"Ferretti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Branger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Roupr\u00eat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"12S","key":"10.1016\/j.purol.2022.08.010_bib0265","doi-asserted-by":"crossref","first-page":"S331","DOI":"10.1016\/S1166-7087(20)30756-9","article-title":"[French ccAFU guidelines\u00a0\u2013\u00a0update 2020\u20132022: malignancy assessment of an adrenal incidentaloma]","volume":"30","author":"Savoie","year":"2020","journal-title":"Prog Urol"},{"issue":"8","key":"10.1016\/j.purol.2022.08.010_bib0270","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1016\/j.jacr.2017.05.001","article-title":"Management of incidental adrenal masses: a white paper of the ACR Incidental Findings Committee","volume":"14","author":"Mayo-Smith","year":"2017","journal-title":"J Am Coll Radiol"},{"issue":"6","key":"10.1016\/j.purol.2022.08.010_bib0275","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1067\/j.cpradiol.2018.10.002","article-title":"A multimodality review of adrenal tumors","volume":"48","author":"Bhargava","year":"2019","journal-title":"Curr Probl Diagn Radiol"},{"issue":"2","key":"10.1016\/j.purol.2022.08.010_bib0280","doi-asserted-by":"crossref","first-page":"G1","DOI":"10.1530\/EJE-16-0467","article-title":"Management of adrenal incidentalomas: European Society of Endocrinology Clinical Practice Guideline in collaboration with the European Network for the Study of Adrenal Tumors","volume":"175","author":"Fassnacht","year":"2016","journal-title":"Eur J Endocrinol"},{"issue":"5","key":"10.1016\/j.purol.2022.08.010_bib0285","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.2214\/AJR.07.2799","article-title":"The incidental adrenal mass on CT: prevalence of adrenal disease in 1049 consecutive adrenal masses in patients with no known malignancy","volume":"190","author":"Song","year":"2008","journal-title":"AJR Am J Roentgenol"},{"issue":"1","key":"10.1016\/j.purol.2022.08.010_bib0290","first-page":"1","article-title":"Incidentalomes surr\u00e9naliens","volume":"31","author":"Haissaguerre","year":"2020","journal-title":"EMC - Endocrinologie-Nutrition"},{"issue":"9","key":"10.1016\/j.purol.2022.08.010_bib0295","doi-asserted-by":"crossref","first-page":"3296","DOI":"10.1210\/jc.2017-00992","article-title":"Malignant pheochromocytoma and paraganglioma: 272 patients over 55 years","volume":"102","author":"Hamidi","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"10.1016\/j.purol.2022.08.010_bib0300","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/j.amjsurg.2010.04.012","article-title":"Malignant pheochromocytoma: a review","volume":"201","author":"Harari","year":"2011","journal-title":"Am J Surg"},{"issue":"6","key":"10.1016\/j.purol.2022.08.010_bib0305","doi-asserted-by":"crossref","first-page":"e409","DOI":"10.1016\/j.jviscsurg.2011.07.003","article-title":"Pheochromocytoma and abdominal paraganglioma","volume":"148","author":"Renard","year":"2011","journal-title":"J Visc Surg"},{"issue":"5","key":"10.1016\/j.purol.2022.08.010_bib0310","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.jviscsurg.2014.07.002","article-title":"Management of adrenal incidentaloma","volume":"151","author":"Menegaux","year":"2014","journal-title":"J Visc Surg"},{"issue":"6","key":"10.1016\/j.purol.2022.08.010_bib0315","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1016\/j.surg.2004.05.058","article-title":"Should pheochromocytoma size influence surgical approach? A comparison of 90 malignant and 60 benign pheochromocytomas","volume":"136","author":"Shen","year":"2004","journal-title":"Surgery"},{"issue":"2","key":"10.1016\/j.purol.2022.08.010_bib0320","doi-asserted-by":"crossref","first-page":"R51","DOI":"10.1530\/EJE-16-0461","article-title":"Management of endocrine disease: imaging for the diagnosis of malignancy in incidentally discovered adrenal masses: a systematic review and meta-analysis","volume":"175","author":"Dinnes","year":"2016","journal-title":"Eur J Endocrinol"},{"issue":"5","key":"10.1016\/j.purol.2022.08.010_bib0325","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1530\/EJE-17-1056","article-title":"Diagnostic accuracy of computed tomography to identify adenomas among adrenal incidentalomas in an endocrinological population","volume":"178","author":"Marty","year":"2018","journal-title":"Eur J Endocrinol"},{"issue":"3","key":"10.1016\/j.purol.2022.08.010_bib0330","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.bulcan.2019.01.002","article-title":"[Update of the recommendations of good clinical practice for the use of PET in oncology]","volume":"106","author":"Sala\u00fcn","year":"2019","journal-title":"Bull Cancer"},{"issue":"5","key":"10.1016\/j.purol.2022.08.010_bib0335","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1097\/00000478-200205000-00002","article-title":"Pheochromocytoma of the Adrenal gland Scaled Score (PASS) to separate benign from malignant neoplasms: a clinicopathologic and immunophenotypic study of 100 cases","volume":"26","author":"Thompson","year":"2002","journal-title":"Am J Surg Pathol"},{"issue":"4","key":"10.1016\/j.purol.2022.08.010_bib0340","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1002\/bjs.10414","article-title":"European Society of Endocrine Surgeons (ESES) and European Network for the Study of Adrenal Tumours (ENSAT) recommendations for the surgical management of adrenocortical carcinoma","volume":"104","author":"Gaujoux","year":"2017","journal-title":"Br J Surg"},{"key":"10.1016\/j.purol.2022.08.010_bib0345","doi-asserted-by":"crossref","first-page":"45","DOI":"10.3389\/fcell.2015.00045","article-title":"Adrenocortical carcinoma (ACC): diagnosis, prognosis, and treatment","volume":"3","author":"Lib\u00e9","year":"2015","journal-title":"Front Cell Dev Biol"},{"issue":"7","key":"10.1016\/j.purol.2022.08.010_bib0350","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1007\/s00259-015-3268-2","article-title":"Prospective comparison of (68)Ga-DOTATATE and (18)F-FDOPA PET\/CT in patients with various pheochromocytomas and paragangliomas with emphasis on sporadic cases","volume":"43","author":"Archier","year":"2016","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"12","key":"10.1016\/j.purol.2022.08.010_bib0355","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1007\/s00259-012-2215-8","article-title":"EANM 2012 guidelines for radionuclide imaging of phaeochromocytoma and paraganglioma","volume":"39","author":"Ta\u00efeb","year":"2012","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"6","key":"10.1016\/j.purol.2022.08.010_bib0360","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1210\/jc.2014-1498","article-title":"Pheochromocytoma and paraganglioma: an endocrine society clinical practice guideline","volume":"99","author":"Lenders","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"10.1016\/j.purol.2022.08.010_bib0365","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.ando.2008.09.003","article-title":"Exploration and management of adrenal incidentalomas. French Society of Endocrinology Consensus","volume":"69","author":"Tabarin","year":"2008","journal-title":"Ann Endocrinol (Paris)"},{"issue":"4","key":"10.1016\/j.purol.2022.08.010_bib0370","doi-asserted-by":"crossref","first-page":"G1","DOI":"10.1530\/EJE-18-0608","article-title":"European Society of Endocrinology Clinical Practice Guidelines on the management of adrenocortical carcinoma in adults, in collaboration with the European Network for the Study of Adrenal Tumors","volume":"179","author":"Fassnacht","year":"2018","journal-title":"Eur J Endocrinol"},{"issue":"5","key":"10.1016\/j.purol.2022.08.010_bib0375","doi-asserted-by":"crossref","first-page":"450","DOI":"10.4158\/EP.15.5.450","article-title":"American Association of Clinical Endocrinologists and American Association of Endocrine Surgeons Medical Guidelines for the Management of Adrenal Incidentalomas: executive summary of recommendations","volume":"15","author":"Zeiger","year":"2009","journal-title":"Endocr Pract"},{"issue":"16","key":"10.1016\/j.purol.2022.08.010_bib0380","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1056\/NEJMcp2031112","article-title":"Adrenal incidentaloma","volume":"384","author":"Kebebew","year":"2021","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.purol.2022.08.010_bib0385","doi-asserted-by":"crossref","first-page":"107","DOI":"10.7326\/M18-3630","article-title":"Natural history of adrenal incidentalomas with and without mild autonomous cortisol excess: a systematic review and meta-analysis","volume":"171","author":"Elhassan","year":"2019","journal-title":"Ann Intern Med"},{"issue":"4","key":"10.1016\/j.purol.2022.08.010_bib0390","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1016\/j.path.2019.08.010","article-title":"Treatment of adrenocortical carcinoma","volume":"12","author":"Vaidya","year":"2019","journal-title":"Surg Pathol Clin"},{"issue":"5\u20136","key":"10.1016\/j.purol.2022.08.010_bib0395","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.ando.2019.09.001","article-title":"Adrenocortical carcinoma: impact of surgical treatment","volume":"80","author":"Miralli\u00e9","year":"2019","journal-title":"Ann Endocrinol (Paris)"},{"issue":"8","key":"10.1016\/j.purol.2022.08.010_bib0400","doi-asserted-by":"crossref","first-page":"2308","DOI":"10.1245\/s10434-018-6546-y","article-title":"Role of additional organ resection in adrenocortical carcinoma: analysis of 167 patients from the US Adrenocortical Carcinoma Database","volume":"25","author":"Marincola Smith","year":"2018","journal-title":"Ann Surg Oncol"},{"issue":"4","key":"10.1016\/j.purol.2022.08.010_bib0405","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/j.suc.2019.04.012","article-title":"Adrenocortical cancer treatment","volume":"99","author":"Long","year":"2019","journal-title":"Surg Clin North Am"},{"issue":"2","key":"10.1016\/j.purol.2022.08.010_bib0410","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1007\/s00268-017-4290-2","article-title":"Minimally invasive adrenalectomy for adrenocortical carcinoma: five-year trends and predictors of conversion","volume":"42","author":"Calcatera","year":"2018","journal-title":"World J Surg"},{"issue":"1","key":"10.1016\/j.purol.2022.08.010_bib0415","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1245\/s10434-013-3164-6","article-title":"Long-term survival after adrenalectomy for stage I\/II adrenocortical carcinoma (ACC): a retrospective comparative cohort study of laparoscopic versus open approach","volume":"21","author":"Donatini","year":"2014","journal-title":"Ann Surg Oncol"},{"issue":"2","key":"10.1016\/j.purol.2022.08.010_bib0420","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/s13304-017-0448-6","article-title":"Robot-assisted adrenalectomy: indications and drawbacks","volume":"69","author":"Nomine-Criqui","year":"2017","journal-title":"Updates Surg"},{"issue":"11","key":"10.1016\/j.purol.2022.08.010_bib0425","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1016\/j.annonc.2020.08.2099","article-title":"Adrenocortical carcinomas and malignant phaeochromocytomas: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"31","author":"Fassnacht","year":"2020","journal-title":"Ann Oncol"},{"issue":"1","key":"10.1016\/j.purol.2022.08.010_bib0430","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.surg.2017.05.029","article-title":"Hemodynamic instability during surgery for pheochromocytoma: comparing the transperitoneal and retroperitoneal approach in a multicenter analysis of 341 patients","volume":"163","author":"Vorselaars","year":"2018","journal-title":"Surgery"},{"issue":"6","key":"10.1016\/j.purol.2022.08.010_bib0435","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1245\/s10434-016-5739-5","article-title":"Surgical treatment of malignant pheochromocytoma and paraganglioma: retrospective case series","volume":"24","author":"Strajina","year":"2017","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.purol.2022.08.010_bib0440","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.jss.2019.05.042","article-title":"Conversion during laparoscopic adrenalectomy for pheochromocytoma: a cohort study in 244 patients","volume":"243","author":"Schweitzer","year":"2019","journal-title":"J Surg Res"},{"issue":"5","key":"10.1016\/j.purol.2022.08.010_bib0445","doi-asserted-by":"crossref","first-page":"G1","DOI":"10.1530\/EJE-16-0033","article-title":"European Society of Endocrinology Clinical Practice Guideline for long-term follow-up of patients operated on for a phaeochromocytoma or a paraganglioma","volume":"174","author":"Plouin","year":"2016","journal-title":"Eur J Endocrinol"},{"issue":"1","key":"10.1016\/j.purol.2022.08.010_bib0450","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1186\/s12893-020-00824-6","article-title":"Laparoscopic versus open surgery for pheochromocytoma: a meta-analysis","volume":"20","author":"Fu","year":"2020","journal-title":"BMC Surg"},{"key":"10.1016\/j.purol.2022.08.010_bib0455","unstructured":"comete 2014 thesaurus. [Disponible sur\u00a0: https:\/\/www.sfendocrino.org\/_images\/mediatheque\/articles\/pdf\/INCAComete\/2014_thesaurus_pheo_pgl_malins_comete_cancer_version_web.pdf]."},{"issue":"6","key":"10.1016\/j.purol.2022.08.010_bib0460","doi-asserted-by":"crossref","first-page":"bnaa008","DOI":"10.1210\/endrev\/bnaa008","article-title":"Adrenal incidentaloma","volume":"41","author":"Sherlock","year":"2020","journal-title":"Endocr Rev"},{"issue":"10","key":"10.1016\/j.purol.2022.08.010_bib0465","doi-asserted-by":"crossref","first-page":"E161","DOI":"10.1210\/jc.2010-0653","article-title":"High diagnostic and prognostic value of steroidogenic factor-1 expression in adrenal tumors","volume":"95","author":"Sbiera","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.purol.2022.08.010_bib0470","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1097\/00000478-198903000-00004","article-title":"Pathologic features of prognostic significance in adrenocortical carcinoma","volume":"13","author":"Weiss","year":"1989","journal-title":"Am J Surg Pathol"},{"issue":"3","key":"10.1016\/j.purol.2022.08.010_bib0475","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1177\/106689690401200304","article-title":"Adrenocortical oncocytic tumors: report of 10 cases and review of the literature","volume":"12","author":"Bisceglia","year":"2004","journal-title":"Int J Surg Pathol"},{"key":"10.1016\/j.purol.2022.08.010_bib0480","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.humpath.2016.09.035","article-title":"Validation of the prognostic role of the \u201cHelsinki Score\u201d in 225 cases of adrenocortical carcinoma","volume":"62","author":"Duregon","year":"2017","journal-title":"Hum Pathol"},{"issue":"2","key":"10.1016\/j.purol.2022.08.010_bib0485","first-page":"93","article-title":"The Eighth Edition AJCC Cancer Staging Manual: continuing to build a bridge from a population-based to a more \u201cpersonalized\u201d approach to cancer staging","volume":"67","author":"Amin","year":"2017","journal-title":"CA Cancer J Clin"},{"issue":"10","key":"10.1016\/j.purol.2022.08.010_bib0490","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1093\/annonc\/mdv329","article-title":"Prognostic factors in stage III-IV adrenocortical carcinomas (ACC): an European Network for the Study of Adrenal Tumor (ENSAT) study","volume":"26","author":"Lib\u00e9","year":"2015","journal-title":"Ann Oncol"},{"issue":"4","key":"10.1016\/j.purol.2022.08.010_bib0495","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1016\/j.eururo.2013.11.006","article-title":"Prognostic role of overt hypercortisolism in completely operated patients with adrenocortical cancer","volume":"65","author":"Berruti","year":"2014","journal-title":"Eur Urol"},{"issue":"1","key":"10.1016\/j.purol.2022.08.010_bib0500","doi-asserted-by":"crossref","first-page":"S42","DOI":"10.1016\/j.annpat.2008.09.010","article-title":"[Pheochromocytoma and the diagnosis of malignancy: recent data and the role of the pathologist]","volume":"28 Spec No 1","author":"Patey","year":"2008","journal-title":"Ann Pathol"},{"issue":"4","key":"10.1016\/j.purol.2022.08.010_bib0505","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1097\/PAS.0b013e318190d12e","article-title":"Observer variation in the application of the Pheochromocytoma of the Adrenal Gland Scaled Score","volume":"33","author":"Wu","year":"2009","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.purol.2022.08.010_bib0510","series-title":"WHO classification of tumours of endocrine organs. Undefined [Internet]","author":"Lloyd","year":"2017"},{"issue":"2","key":"10.1016\/j.purol.2022.08.010_bib0515","doi-asserted-by":"crossref","first-page":"E225","DOI":"10.3390\/cancers11020225","article-title":"The value of histological algorithms to predict the malignancy potential of pheochromocytomas and abdominal paragangliomas\u00a0\u2013\u00a0a meta-analysis and systematic review of the literature","volume":"11","author":"Stenman","year":"2019","journal-title":"Cancers (Basel)"},{"issue":"1","key":"10.1016\/j.purol.2022.08.010_bib0520","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1186\/s40425-019-0722-x","article-title":"Phase II clinical trial of pembrolizumab efficacy and safety in advanced adrenocortical carcinoma","volume":"7","author":"Habra","year":"2019","journal-title":"J Immunother Cancer"}],"container-title":["Progr\u00e8s en Urologie"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1166708722003876?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1166708722003876?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T06:37:42Z","timestamp":1761115062000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1166708722003876"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":52,"journal-issue":{"issue":"15","published-print":{"date-parts":[[2022,11]]}},"alternative-id":["S1166708722003876"],"URL":"https:\/\/doi.org\/10.1016\/j.purol.2022.08.010","relation":{},"ISSN":["1166-7087"],"issn-type":[{"value":"1166-7087","type":"print"}],"subject":[],"published":{"date-parts":[[2022,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"French AFU Cancer Committee Guidelines Update 2022\u20132024: Adrenal tumor\u00a0\u2013\u00a0 Assessment of an adrenal incidetaloma and oncological management","name":"articletitle","label":"Article Title"},{"value":"Progr\u00e8s en Urologie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.purol.2022.08.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}